GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+98.85%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$370M
AUM Growth
+$370M
(+29%)
Cap. Flow
-$62.6M
Cap. Flow
% of AUM
-16.9%
Top 10 Holdings %
Top 10 Hldgs %
49.75%
Holding
62
New
19
Increased
13
Reduced
12
Closed
13
Top Buys
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$27.1M |
| 2 |
Immunovant
IMVT
|
$12.7M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$12.2M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$8.46M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$8.03M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$49.1M |
| 2 |
Sarepta Therapeutics
SRPT
|
$20M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$16.9M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$16.1M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$15.4M |
Sector Composition
| 1 | Healthcare | 90.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $27.8M | 5.3% | 200,000 +50,000 | +33% | +$6.96M |
|
|
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $27.1M | 5.16% | +575,500 | New | +$27.1M |
|
|
3
Axsome Therapeutics
AXSM
$6.05B
| $20.7M | 3.94% | 200,000 -475,000 | -70% | -$49.1M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $19.3M | 3.68% | 150,000 -125,000 | -45% | -$16.1M |
|
5
Iovance Biotherapeutics
IOVA
$807M
| $18M | 3.43% | 650,000 +150,000 | +30% | +$4.15M |
|
6
Rocket Pharmaceuticals
RCKT
$354M
| $15.9M | 3.03% | 700,000 +75,000 | +12% | +$1.71M |
|
|
RETA
7
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $15.3M | 2.92% | 75,000 +25,000 | +50% | +$5.11M |
|
|
AERI
8
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $13.9M | 2.65% | 575,000 +350,000 | +156% | +$8.46M |
|
9
Adverum Biotechnologies
ADVM
$64.6M
| $13.5M | 2.58% | 1,175,000 -275,000 | -19% | -$3.17M |
|
|
10
Immunovant
IMVT
$2.56B
| $12.7M | 2.42% | +800,000 | New | +$12.7M |
|
11
Amicus Therapeutics
FOLD
$2.34B
| $12.2M | 2.32% | 1,250,000 -455,000 | -27% | -$4.43M |
|
|
12
Aurinia Pharmaceuticals
AUPH
$1.58B
| $12.2M | 2.31% | +600,000 | New | +$12.2M |
|
|
BPMC
13
DELISTED
Blueprint Medicines
BPMC
| $12M | 2.29% | 150,000 -175,000 | -54% | -$14M |
|
|
IMMU
14
DELISTED
Immunomedics Inc
IMMU
| $10.6M | 2.01% | 500,000 -225,000 | -31% | -$4.76M |
|
15
BioCryst Pharmaceuticals
BCRX
$1.74B
| $10.4M | 1.97% | 3,000,000 +1,500,000 | +100% | +$5.18M |
|
16
Arvinas
ARVN
$568M
| $9.25M | 1.76% | 225,000 +40,000 | +22% | +$1.64M |
|
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $8.39M | 1.6% | 65,000 -155,000 | -70% | -$20M |
|
|
DBVT
18
DBV Technologies
DBVT
$264M
| $8.03M | 1.53% | +750,000 | New | +$8.03M |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $7.89M | 1.5% | 400,000 +50,000 | +14% | +$987K |
|
20
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $7.74M | 1.47% | +430,000 | New | +$7.74M |
|
21
KalVista Pharmaceuticals
KALV
$678M
| $7.39M | 1.41% | 415,000 +100,000 | +32% | +$1.78M |
|
|
MYOV
22
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.98M | 1.33% | +450,000 | New | +$6.98M |
|
|
ISEE
23
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.44M | 1.23% | +750,000 | New | +$6.44M |
|
|
ARQL
24
DELISTED
Arqule Inc
ARQL
| $5.99M | 1.14% | +300,000 | New | +$5.99M |
|
25
Fate Therapeutics
FATE
$120M
| $5.38M | 1.02% | 275,000 -75,000 | -21% | -$1.47M |
|